| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/28/2004 | EP1383481A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 01/28/2004 | EP1383478A2 Skin composition |
| 01/28/2004 | EP1383474A2 Methods and compositions that affect melanogenesis (pfi-016cip/pct) |
| 01/28/2004 | EP1383465A2 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| 01/28/2004 | EP1383464A1 Nail compositions and methods of administering same |
| 01/28/2004 | EP1383463A2 Pharmaceutically active compounds and methods of use |
| 01/28/2004 | EP1383460A2 Crf 2? ligands in combination therapy |
| 01/28/2004 | EP1383447A1 Stent-based delivery of statins to prevent restenosis |
| 01/28/2004 | EP1383445A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 01/28/2004 | EP1383399A1 Nutritional supplement to treat macular degeneration |
| 01/28/2004 | EP1383391A1 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 01/28/2004 | EP1383385A1 Use of ppar-alpha-gamma ligands or agonists to prevent the rupture of atherosclerotic plaques |
| 01/28/2004 | EP1383379A1 Restoration of cancer-suppressing functions to neoplastic cells through dna hypomethylation |
| 01/28/2004 | EP1313706A4 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | EP1296676B1 Use of indole-3-acetic acid derivatives in medicine |
| 01/28/2004 | EP1268479B1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 01/28/2004 | EP1267798A4 Treatment of skin damage using polyenylphosphatidylcholine |
| 01/28/2004 | EP1218382B1 Bicyclic imidazo-3-yl-amine derivatives |
| 01/28/2004 | EP1217990B1 Cationic dosper virosomes |
| 01/28/2004 | EP1214077B1 Local delivery of 17-beta estradiol for improving vascular endothelium function after vascular injury |
| 01/28/2004 | EP1214066A4 Formation of nanometer-scale structures |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 01/28/2004 | EP1082322B1 Oxazolidinone derivatives as antibiotic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/28/2004 | EP1071397B1 Controlled release peroral compositions of levosimendan |
| 01/28/2004 | EP1058541B1 Sustained-release preparation for aii antagonist, production and use thereof |
| 01/28/2004 | EP0994657B1 Palatable elemental medical food |
| 01/28/2004 | EP0966455B1 Oxiran carboxylic acids for the treatment of diabetes |
| 01/28/2004 | EP0959889B1 Use of neutral gallium chelates of 3-hydroxy-4-pyrone compounds for the treatment of diseases that can be ameliorated by inhibiting keratinocyte hyperproliferation |
| 01/28/2004 | EP0921789B1 Taste masked liquid suspensions |
| 01/28/2004 | EP0918790B1 Polycationic sterol derivatives as transfection agents |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | EP0906100B1 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence |
| 01/28/2004 | EP0842290B1 Process for the preparation of lovastatin |
| 01/28/2004 | EP0841927B1 Quinolones and their therapeutic use |
| 01/28/2004 | EP0839028B1 Solid dispersions of rapamycin |
| 01/28/2004 | EP0782442B1 A delivery system for antimethanogenic agents comprising cyclodextrin and antimethanogenic agents |
| 01/28/2004 | EP0708829B1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 01/28/2004 | EP0708637B1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471535A Tricyclic derivatives of indole with antiangiogenic activity |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471531A Thiazolidinone nitrate salt |
| 01/28/2004 | CN1471530A A thiazolidinedione derivative and its use as antidiabetic |
| 01/28/2004 | CN1471529A A thiazolidniedione derivative and its use as antidiabetic |
| 01/28/2004 | CN1471527A 喹唑啉衍生物 Quinazoline derivatives |
| 01/28/2004 | CN1471526A Dioxolane analogs for improved inter-cellular delivery |
| 01/28/2004 | CN1471525A Triazole derivatives and pharmaceutical compounds comprising them |
| 01/28/2004 | CN1471524A Novel farnesyl protein transferase inhibitors as antitumor |
| 01/28/2004 | CN1471523A Imidazole derivatives as Raf kinase inhibitors |
| 01/28/2004 | CN1471522A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471519A Amino alkyenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471517A OXAZOLYL-arylpropionic acid derivatives and their sue as PPAR agonists |
| 01/28/2004 | CN1471515A Compounds effective as beta-2-adrenoreceptor agonists as well as PDE-4-inhibitors |
| 01/28/2004 | CN1471514A Novel M-amino-phenylimino-imidazolidone derivatives for treating urinary incontinence |
| 01/28/2004 | CN1471512A Gem-substituted ± ¢ ²3 integrin antagonists |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1471509A 9-substituted minocycline compounds |
| 01/28/2004 | CN1471508A Selective androgen receptor modulators and methods of use thereof |
| 01/28/2004 | CN1471408A Methods of treatment of a BCL-2 disorder using BCL-2 antisense oligomers |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1471404A Antiparkinsonism drugs |
| 01/28/2004 | CN1471401A Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/28/2004 | CN1471400A Combination therapy for the treatment of estrogen-sensitive disease |
| 01/28/2004 | CN1471399A Cephalosporin antibiotics and prodrugs thereof |
| 01/28/2004 | CN1471398A Controlled release formulations for oral administration |
| 01/28/2004 | CN1471397A Method for treatment of migraine |
| 01/28/2004 | CN1471396A A combination comprising camptothecin and a stilbene derivative for the treatment of cancer |
| 01/28/2004 | CN1471395A Apomorphine derivatives and methods for their use |
| 01/28/2004 | CN1471394A Tripeptidyl peptidase inhibitors |
| 01/28/2004 | CN1471393A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1471392A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1471391A Composition and method for treatment of hypertriglyceridemia |
| 01/28/2004 | CN1471390A Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
| 01/28/2004 | CN1471389A Ibuprofen solutions for capsule-filling and capsule preparations |
| 01/28/2004 | CN1471387A Oral dosage self-emulsifying formulations of pyranone proteinase inhibitors |
| 01/28/2004 | CN1471364A Materials and method for the treatment or prevention of obesity |
| 01/28/2004 | CN1470637A Hepatitis B virus core protein mutant and its use |
| 01/28/2004 | CN1470533A Method for preparing low-molecular-weight chondroitin sulfate |
| 01/28/2004 | CN1470517A Composition containing crystalline and non-crystalline Aide-diester and use thereof |
| 01/28/2004 | CN1470516A Gambogic aid compound complex, its preparing method and medicinal composition containing the complex as active ingredient |
| 01/28/2004 | CN1470513A Total alkaloid with anticancer activity and its formulation |
| 01/28/2004 | CN1470289A Polymeric nano medicine carrier and preparation preparing method |
| 01/28/2004 | CN1470286A Medicinal composition for immunopotentiation and its preparing method |
| 01/28/2004 | CN1470269A Lingjingchuandu compound preparation for treating non-typical pneumonia |
| 01/28/2004 | CN1470258A Chinese medicine for treating chest paralysis |
| 01/28/2004 | CN1470255A Preparation extracted from the root of red-rooted solvia and pseudo-ginseng and its compound preparation and medical use |
| 01/28/2004 | CN1470246A Liquid antiacid composition |
| 01/28/2004 | CN1470245A Low-molecular-weight chondroitin sulfate injecta and its preparation method |
| 01/28/2004 | CN1470244A Use of N-acetyl-D-aminoglucose in preparation of skin membrane mucosa microecologica balance regulator medicines |
| 01/28/2004 | CN1470243A Use of N-acetyl-D-aminoglucose in preparation of anti-tumor and anti-tumor-transition medicines |
| 01/28/2004 | CN1470242A 4-de-dimethyltetracycline derivative use |
| 01/28/2004 | CN1470241A Astragalus root methyl-glycoside composition and preparation method |
| 01/28/2004 | CN1470240A Controllable release system of glucocorticoid and its preparation and use |
| 01/28/2004 | CN1470239A Testosterone intradermic sustained preparation |
| 01/28/2004 | CN1470238A Levosimendan formulation and its preparing method |
| 01/28/2004 | CN1470237A Use of chloroquine, hydroxychloroquine and 4-aminoquinazine derivatives in preparing medicine for antiretrovirus therapy |